Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
[Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].
Effect of wearing a dorsiflexion assist orthosis on mobility, perceived fatigue and exertion during the six-minute walk test in people with multiple sclerosis: a randomised cross-over protocol.
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.
Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.
The pill times 2: What every woman with multiple sclerosis should know.
Glial contributions to neural function and disease.
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.
MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?
JC viremia in natalizumab-treated patients with multiple sclerosis.
Enrollment complete for cannabinoid MS study
The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.
Scrub typhus with longitudinally extensive transverse myelitis.
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
Multiple Sclerosis: Myeloperoxidase Immunoradiology Improves Detection of Acute and Chronic Disease in Experimental Model.
Tumefactive MS lesions under fingolimod: A case report and literature review.
Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
Simvastatin in acute optic neuritis.
Prevalence of stress urinary incontinence in women with multiple sclerosis.
Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2-Year Observational Study.
Evaluating medically at-risk drivers: a survey of assessment practices in Canada.
Obstructive sleep apnea and fatigue in patients with multiple sclerosis.

Pages